Serosurveillance after a COVID-19 Vaccine Campaign in a Swiss Police Cohort
Publisher DOI
PubMed ID
35759237
Abstract
Introduction: To assess the risk for COVID-19 of police officers, we are studying the seroprevalence in a cohort. The baseline cross-sectional investigation was performed prior to a vaccination campaign in January/February 2021, and demonstrated a seroprevalence of 12.9%. Here, we demonstrate serosurveillance results after a vaccination campaign.
Methods: The cohort consists of 1022 study participants. The 3-month and 6-month follow-up visits were performed in April/May and September 2021. Data on infection and vaccination rates were obtained via measuring antibodies to the nucleocapsid protein and spike protein and online questionnaires.
Results: The mean age of the population was 41 (SD 8.8) years, 72% were male and 76% had no comorbidity. Seroconversion was identified in 1.05% of the study population at the 3-month visit and in 0.73% at the 6-month visit, resulting in an infection rate of 1.8% over a time period of 6 months. In comparison, the infection rate in the general population over the same time period was higher (3.18%, P=0.018). At the 6-month visit, 77.8% of participants reported being vaccinated once and 70.5% twice; 81% had an anti-S antibody titer of >250 U/mL and 87.1% of ≥2 U/mL. No significant association between infection and job role within the department, working region, or years of experience in the job was found. Anti-spike antibody titers of vaccinated study participants showed a calculated decreasing trend 150 to 200 days after the second vaccine dose.
Conclusion: These data confirm the value of the vaccination campaign in an exposed group other than healthcare professionals.
Methods: The cohort consists of 1022 study participants. The 3-month and 6-month follow-up visits were performed in April/May and September 2021. Data on infection and vaccination rates were obtained via measuring antibodies to the nucleocapsid protein and spike protein and online questionnaires.
Results: The mean age of the population was 41 (SD 8.8) years, 72% were male and 76% had no comorbidity. Seroconversion was identified in 1.05% of the study population at the 3-month visit and in 0.73% at the 6-month visit, resulting in an infection rate of 1.8% over a time period of 6 months. In comparison, the infection rate in the general population over the same time period was higher (3.18%, P=0.018). At the 6-month visit, 77.8% of participants reported being vaccinated once and 70.5% twice; 81% had an anti-S antibody titer of >250 U/mL and 87.1% of ≥2 U/mL. No significant association between infection and job role within the department, working region, or years of experience in the job was found. Anti-spike antibody titers of vaccinated study participants showed a calculated decreasing trend 150 to 200 days after the second vaccine dose.
Conclusion: These data confirm the value of the vaccination campaign in an exposed group other than healthcare professionals.
Date Issued
2022-07
Publication Type
Article
Language(s)
en
Author(s)
Thierstein, Marc | |
Widmer, Nadja | |
Tinguely, Caroline | |
Theel, Elitza S. | |
Berbari, Elie | |
Gowland, Peter |
Journal
Immunity, inflammation and disease
Publisher
Wiley
ISSN
2050-4527
Access(Rights)
open.access